Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
KROS
$10.08
+5.66%
KROS
· Keros Therapeutics, Inc.
$10.08
+0.54 (+5.66%)
At close · Nov 12
Return incl. dividend (before tax)
Market Cap
$197.81M
Shares
19.62M
Volume · Nov 12
630.16K
Avg daily vol (3M)
187.94K
All webcasts
Earnings call · FY2023 Q2
Keros Therapeutics, Inc. (KROS) Q2 2023 Earnings Call
Revenue
$0
Diluted EPS
-$1.27
Net income
-$37.51M
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 7, 2023 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 7, 2023 · complete as-filed document